120 related articles for article (PubMed ID: 9466528)
1. Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis.
Perides G; Charness ME; Tanner LM; Péter O; Satz N; Steere AC; Klempner MS
J Infect Dis; 1998 Feb; 177(2):401-8. PubMed ID: 9466528
[TBL] [Abstract][Full Text] [Related]
2. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.
Friedberg MH; Glantz MJ; Klempner MS; Cole BF; Perides G
Cancer; 1998 Mar; 82(5):923-30. PubMed ID: 9486583
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status.
Mäkelä M; Salo T; Uitto VJ; Larjava H
J Dent Res; 1994 Aug; 73(8):1397-406. PubMed ID: 8083435
[TBL] [Abstract][Full Text] [Related]
4. Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion.
Azeh I; Mäder M; Smirnov A; Beuche W; Nau R; Weber F
Neurosci Lett; 1998 Nov; 256(3):127-30. PubMed ID: 9855356
[TBL] [Abstract][Full Text] [Related]
5. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms.
Sakalihasan N; Delvenne P; Nusgens BV; Limet R; Lapière CM
J Vasc Surg; 1996 Jul; 24(1):127-33. PubMed ID: 8691515
[TBL] [Abstract][Full Text] [Related]
6. Gelatinolytic and type IV collagenolytic activity in bronchiectasis.
Sepper R; Konttinen YT; Sorsa T; Koski H
Chest; 1994 Oct; 106(4):1129-33. PubMed ID: 7924484
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.
Umehara F; Okada Y; Fujimoto N; Abe M; Izumo S; Osame M
J Neuropathol Exp Neurol; 1998 Sep; 57(9):839-49. PubMed ID: 9737547
[TBL] [Abstract][Full Text] [Related]
8. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury.
Rosenberg GA; Dencoff JE; Correa N; Reiners M; Ford CC
Neurology; 1996 Jun; 46(6):1626-32. PubMed ID: 8649561
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of matrix metalloproteinase-9 in the cerebrospinal fluid of patients with acute Lyme neuroborreliosis.
Kirchner A; Koedel U; Fingerle V; Paul R; Wilske B; Pfister HW
J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):368-71. PubMed ID: 10675223
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia.
Conant K; McArthur JC; Griffin DE; Sjulson L; Wahl LM; Irani DN
Ann Neurol; 1999 Sep; 46(3):391-8. PubMed ID: 10482270
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis.
Steere AC; Berardi VP; Weeks KE; Logigian EL; Ackermann R
J Infect Dis; 1990 Jun; 161(6):1203-9. PubMed ID: 2345301
[TBL] [Abstract][Full Text] [Related]
12. A study of metalloproteinases in fifty joint fluid specimens.
Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X
Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases in sterile corneal melts.
Geerling G; Joussen AM; Daniels JT; Mulholland B; Khaw PT; Dart JK
Ann N Y Acad Sci; 1999 Jun; 878():571-4. PubMed ID: 10415776
[No Abstract] [Full Text] [Related]
14. Differential expression of matrix metalloproteinases in bacterial meningitis.
Kieseier BC; Paul R; Koedel U; Seifert T; Clements JM; Gearing AJ; Pfister HW; Hartung HP
Brain; 1999 Aug; 122 ( Pt 8)():1579-87. PubMed ID: 10430840
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid and serum neopterin levels in patients with Lyme neuroborreliosis.
Dotevall L; Fuchs D; Reibnegger G; Wachter H; Hagberg L
Infection; 1990; 18(4):210-4. PubMed ID: 2210852
[TBL] [Abstract][Full Text] [Related]
16. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P
J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve.
Kherif S; Dehaupas M; Lafuma C; Fardeau M; Alameddine HS
Neuropathol Appl Neurobiol; 1998 Aug; 24(4):309-19. PubMed ID: 9775397
[TBL] [Abstract][Full Text] [Related]
18. Characterization of an endogenous metalloproteinase in human vitreous.
Brown D; Hamdi H; Bahri S; Kenney MC
Curr Eye Res; 1994 Sep; 13(9):639-47. PubMed ID: 7805394
[TBL] [Abstract][Full Text] [Related]
19. Gelatinases/type IV collagenases in jaw cyst expansion.
Teronen O; Salo T; Konttinen YT; Rifkin B; Vernillo A; Ramamurthy NS; Kjeldsen L; Borregaard N; Sommerhoff CP; Sorsa T
Ann N Y Acad Sci; 1994 Sep; 732():486-8. PubMed ID: 7978847
[No Abstract] [Full Text] [Related]
20. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.
Lindberg RL; Sorsa T; Tervahartiala T; Hoffmann F; Mellanen L; Kappos L; Schaad UB; Leib SL; Leppert D
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):304-17. PubMed ID: 16640649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
